Yongfei Li

896 citations
33 papers · 688 indexed · h-index 13
Topics
Cell Adhesion Molecules Research (8 papers)RNA modifications and cancer (5 papers)HER2/EGFR in Cancer Research (4 papers)
Journals
SHILAP Revista de lepidopterologíaThe FASEB JournalFEBS Letters
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Yongfei Li

31 papers receiving 683 citations

Peers

Yongfei Li
Comparison fields: 5 of 85
  • Molecular Biology 454
  • Cancer Research 270
  • Oncology 119
  • Biomedical Engineering 91
  • Immunology 76
Replace Jianwei Zhu with:
Jianwei Zhu China
Ashleigh Pulkoski‐Gross United States
Lorena Benedetti Argentina
Karlien Kallmeyer South Africa
Qingyuan Zhang China
Chen Sun China
Yunfei Wen United States
Arnab Ghosh United States
Byung-Kyu Ryu South Korea
Ju-Ock Nam South Korea
Yongfei Li relative to Jianwei Zhu China Jianwei Zhu's profile →
Citations per field
00.5×1.5×2.5×
Jianwei Zhu · 1×
Citations per year

Countries citing papers authored by Yongfei Li

Since Specialization
Citations

This map shows the geographic impact of Yongfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongfei Li more than expected).

Fields of papers citing papers by Yongfei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongfei Li. The network helps show where Yongfei Li may publish in the future.

Co-authorship network of co-authors of Yongfei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yongfei Li. A scholar is included among the top collaborators of Yongfei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongfei Li. Yongfei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 10
5 4
6 10
7 5
8 9
9 9
10 1
11 39
12 72
13 39
14 112
15 12
16 11
17 57
18 15
19 4
20 5

About Yongfei Li

Yongfei Li is a scholar working on Immunology and Allergy, Cancer Research and Biological Psychiatry, having authored 33 papers that have together received 688 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (8 papers), RNA modifications and cancer (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Cancer Research (270 citations), Immunology and Allergy (57 citations) and Molecular Biology (454 citations). Yongfei Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ziyi Fu, Jiahui Chu, Yanhong Zhang, Yongmei Yin, Xiang Huang, Chunxiao Sun, Fan Yang, Shauna N. Vasilatos, Hiroto Kawashima and Masayuki Miyasaka. Their work appears in journals such as SHILAP Revista de lepidopterología, The FASEB Journal and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026